616 related articles for article (PubMed ID: 19403113)
21. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
Im L; Allingham RR; Singh I; Stinnett S; Fekrat S
J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
[TBL] [Abstract][Full Text] [Related]
22. Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma.
Malone PE; Herndon LW; Muir KW; Jaffe GJ
Am J Ophthalmol; 2010 May; 149(5):800-6.e1. PubMed ID: 20189158
[TBL] [Abstract][Full Text] [Related]
23. Frequency and management of raised intraocular pressure following intravitreal triamcinolone acetonide.
Mahar PS; Memon AS
J Coll Physicians Surg Pak; 2012 Nov; 22(11):699-702. PubMed ID: 23146849
[TBL] [Abstract][Full Text] [Related]
24. Visual acuity and intraocular pressure after Descemet's stripping endothelial keratoplasty in eyes with and without preexisting glaucoma.
Vajaranant TS; Price MO; Price FW; Gao W; Wilensky JT; Edward DP
Ophthalmology; 2009 Sep; 116(9):1644-50. PubMed ID: 19643499
[TBL] [Abstract][Full Text] [Related]
25. Intravitreal triamcinolone acetonide and intraocular pressure.
Smithen LM; Ober MD; Maranan L; Spaide RF
Am J Ophthalmol; 2004 Nov; 138(5):740-3. PubMed ID: 15531307
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of patient age as a risk factor for intraocular pressure elevation after intravitreal triamcinolone.
Shukla D; Vidhya N; Prasad NM; Mahalakshmi R; Kolluru C; Krishnadas R
Am J Ophthalmol; 2007 Sep; 144(3):453-4. PubMed ID: 17765428
[TBL] [Abstract][Full Text] [Related]
27. Adverse events after intravitreal triamcinolone in patients with and without uveitis.
Galor A; Margolis R; Brasil OM; Perez VL; Kaiser PK; Sears JE; Lowder CY; Smith SD
Ophthalmology; 2007 Oct; 114(10):1912-8. PubMed ID: 17908594
[TBL] [Abstract][Full Text] [Related]
28. Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome.
Levkovitch-Verbin H; Habot-Wilner Z; Burla N; Melamed S; Goldenfeld M; Bar-Sela SM; Sachs D
Ophthalmology; 2008 Jan; 115(1):104-8. PubMed ID: 17561259
[TBL] [Abstract][Full Text] [Related]
29. Intraoperative use of intravitreal triamcinolone in uveitic eyes having cataract surgery: pilot study.
Okhravi N; Morris A; Kok HS; Menezo V; Dowler JG; Hykin PG; Lightman S
J Cataract Refract Surg; 2007 Jul; 33(7):1278-83. PubMed ID: 17586387
[TBL] [Abstract][Full Text] [Related]
30. Reduction of intraocular pressure with anecortave acetate in eyes with ocular steroid injection-related glaucoma.
Robin AL; Suan EP; Sjaarda RN; Callanan DG; Defaller J;
Arch Ophthalmol; 2009 Feb; 127(2):173-8. PubMed ID: 19204235
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Jonas JB
Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
[TBL] [Abstract][Full Text] [Related]
32. Ocular complications after a sub-tenon injection of triamcinolone acetonide for uveitis.
Kuo HK; Lai IC; Fang PC; Teng MC
Chang Gung Med J; 2005 Feb; 28(2):85-9. PubMed ID: 15880983
[TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
Dada T; Dhawan M; Garg S; Nair S; Mandal S
J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
[TBL] [Abstract][Full Text] [Related]
34. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
Bournias TE; Lai J
Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
[TBL] [Abstract][Full Text] [Related]
35. [Intraocular pressure elevation after subtenon injection of triamcinolone acetonide during uveitis].
Bui Quoc E; Bodaghi B; Adam R; Burtin T; Cassoux N; Dreifuss S; Fardeau C; LeHoang P
J Fr Ophtalmol; 2002 Dec; 25(10):1048-56. PubMed ID: 12527830
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema.
Androudi S; Letko E; Meniconi M; Papadaki T; Ahmed M; Foster CS
Ocul Immunol Inflamm; 2005; 13(2-3):205-12. PubMed ID: 16019680
[TBL] [Abstract][Full Text] [Related]
37. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
[TBL] [Abstract][Full Text] [Related]
38. The effect of intravitreal triamcinolone on intraocular pressure.
Kramar M; Vu L; Whitson JT; He YG
Curr Med Res Opin; 2007 Jun; 23(6):1253-8. PubMed ID: 17559723
[TBL] [Abstract][Full Text] [Related]
39. Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis.
Chieh JJ; Carlson AN; Jaffe GJ
Am J Ophthalmol; 2008 Oct; 146(4):589-594. PubMed ID: 18639220
[TBL] [Abstract][Full Text] [Related]
40. Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants.
Goldstein DA; Godfrey DG; Hall A; Callanan DG; Jaffe GJ; Pearson PA; Usner DW; Comstock TL
Arch Ophthalmol; 2007 Nov; 125(11):1478-85. PubMed ID: 17923537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]